http://www.acc.org/Feed?clinicalTopicID=332172f7-e818-41a0-976e-9ab92513cae5 Clinical Topic Feed: Acute Coronary Syndromes en /Latest-in-Cardiology/Articles/2026/04/09/13/37/ai-enabled-clinician-09apr2026 In this episode, ACC Chief Innovation Officer Dr. Ami Bhatt speaks with Dr. Todd Villines about the transformative role of AI-enabled coronary CT angiogram (CCTA) and how it is expanding patient access to essential coronary artery disease (CAD) diagnostics. 1775748600000 Articles and Stories /Latest-in-Cardiology/Articles/2026/04/07/19/53/host-exam-acc-2026 Clopidogrel monotherapy after PCI was associated with a significantly lower composite risk of all-cause death, nonfatal MI, stroke, readmission for acute coronary syndrome (ACS) and major bleeding compared with aspirin monotherapy, according to 10-year follow-up results of the HOST-EXAM trial presented as featured clinical research at ACC.26 and published simultaneously in The Lancet. 1775593440000 Articles and Stories /Latest-in-Cardiology/Articles/2022/01/01/01/01/ACC-Featured-Jobs Ready to explore a new professional opportunity? Browse the list below of featured jobs and take the next step in your career! 1775037480000 Articles and Stories /Latest-in-Cardiology/Articles/2026/03/25/21/27/sun-830am-fastIII-acc-2026 Vessel fractional flow reserve (vFFR)-guided revascularization was noninferior to pressure-wire-based fractional flow reserve (FFR)-guided revascularization in patients with intermediate coronary lesions, according to results from the FAST III trial presented during a Late-Breaking Clinical Trials session... 1774791180000 Articles and Stories /Latest-in-Cardiology/Articles/2026/03/18/00/50/eagles-eye-view-18mar2025 In this week’s View, Dr. Eagle looks at data from the STS/ACC TVT Registry on off label transcatheter valve interventions that demonstrate reduced residual tricuspid regurgitation (TR) and improved quality of life. 1773842400000 Articles and Stories /Latest-in-Cardiology/Articles/2026/03/16/16/27/Pre-Hospital-Glycoprotein-IIb-IIIa-Inhibition-With-Zalunfiban-in-STEMI The CELEBRATE (CeleCor Blinded Randomized Trial in ST-Elevation Myocardial Infarction) trial was a phase 3, multicenter, double-blind, placebo-controlled study that evaluated the efficacy and safety of a single subcutaneous injection of zalunfiban (CeleCor Therapeutics), a novel glycoprotein IIb/IIIa inhibitor... 1773751800000 Articles and Stories /Latest-in-Cardiology/Articles/2026/03/11/16/14/eagles-eye-view-11mar2025 In this week’s View, Dr. Eagle looks at the differential effect of bisoprolol versus verapamil in nonobstructive hypertrophic cardiomyopathy (HCM) treatment. 1773245700000 Articles and Stories /Latest-in-Cardiology/Journal-Scans/2026/03/10/16/54/RENOVATE-COMPLEX-PCI-Benefit-With-Intravascular In the multicenter open-label superiority trial, Joo Myung Lee, MD, MPH, PhD, FACC, et al., randomized 1,639 patients (mean age 66; 20% women) with complex coronary artery lesions across 20 hospitals in South Korea 2:1 to either intravascular imaging-guided PCI (n=1,092) or angiography-guided PCI (n=547). Of the overall cohort, 49% presented with stable ischemic heart disease and 51% with an acute coronary syndrome (ACS). Thirty-one percent had three or more characteristics of complex coronary artery lesions in the target lesion. The most common was long coronary lesion, followed by multivessel PCI, true bifurcation lesion and chronic total occlusion. 1773162180000 Articles and Stories /Latest-in-Cardiology/Articles/2026/03/04/12/02/Extended-DAPT-in-Multivessel-CAD The DAPT-MVD (Dual Antiplatelet Therapy in Patients With Coronary Multi-Vessel Disease) trial was a multicenter, randomized, open-label study in China designed to assess whether extending dual antiplatelet therapy (DAPT) beyond 12 months provides additional benefit for patients with multivessel coronary artery disease (CAD)... 1772647140000 Articles and Stories /Latest-in-Cardiology/Articles/2026/03/04/14/11/eagles-eye-view-04mar2025 In this week’s View, Dr. Eagle looks at increased one-year mortality in younger patients undergoing transcatheter aortic valve replacement (TAVR). 1772636400000 Articles and Stories